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The effects of a mucoid - psyllium hy-
drocolloid - and an anion exchange polymer-
cholestryamine - on the total cholesterol, 
total phospholipid, total bile salt, cholate, 
chenodeoxycholate, and deoxycholate con-
centrations of hepatic bile were determined 
in six post-cholecystectomy patients. Bile was 
obtained by drainage through an indwelling 
T-tube, which was clamped except during 
bile collection. Psyllium hydrocolloid treat-
ment (12 gm/day) for 6 to 29 days had little 
or no effect on the cholesterol or 
phospholipid concentration of hepatic bile, 
but increased the total bile salt pool by 
gradually increasing the concentration of 
deoxycholate. Cholestyramine treatment (12 
gm/day) for 8 to 12 days had no significant 
effect on cholesterol, phospholipid or total 
bile salt concentrations. There was a signifi-
cant increase in the tri- to di-hydroxy bile salt 
ratio due to decreases in chenodeoxycholate 
and deoxycholate concentrations. The ratio 
of taurine to glycine conjugates decreased 
because of reductions in concentrations of 
taurine conjugates and compensating 
increases in glycine conjugates. The influ-
ence of these changes on bile micelle stabil-
ity and cholesterol solubility is discussed. It 
is concluded that the changes effected by 
psyllium hydrocolloid may result in more 
stable bile micelles and greater cholesterol 
solubility. No definite conclusions can be 
reached with respect to cholestyramine's 
effects. 
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\A^ORLD-WIDE epidemiological sur-
veys have generated statistical evidence 
which suggests that there is a positive 
correlation between blood cholesterol 
concentration and the incidence of 
atherosclerotic heart disease. These find-
ings have resulted in major efforts to 
develop hypocholesterolemic drugs 
which would presumably lessen the ten-
dency to develop atherosclerosis. Two 
classes of effective drugs have resulted: 
(a) substances that inhibit or retard the 
rate of hepatic cholesterol synthesis, 
and (b) drugs that increase the rate of 
tissue cholesterol elimination via either 
the fecal neutral steroid or bile acid 
pathway. Substances of the latter type 
increase the rate of cholesterol elimina-
tion in certain species, including man, 
to such an extent that hepatic synthesis 
of new cholesterol molecules is unable 
to compensate for the loss, and a reduc-
tion of blood cholesterol concentration 
results. 
Two types of drugs have been found 
that primarily increase tissue cholesterol 
elimination via the fecal bile acid 
pathway. They are the anion exchange 
polymers^-" and the hydrophilic 
mucoids.'-'^ Since these drugs greatly 
increase the rate of elimination of bile 
salts from their enterohepatic circulat-
ing pool, ^'''^ it is possible that they also 
change the size and composition of this 
pool. Such changes could affect the sol-
ubility of cholesterol in bile, since this 
sterol is held in solution in mixed 
micelles containing definite ratios of 
cholesterol, phospholipids and bile 
salts.'-" The stability of bile micelles is of 
interest because changes in micelle 
composition, which affect cholesterol 
solubility, could trigger gallstone forma-
tion or dissolution."-" 
While it might seem reasonable to 
expect the increased rate of elimination 
of bile salts effected by the hydrophilic 
mucoids or anion exchange resins to 
alter biliary micellar lipid ratios, this 
may not be the case since the excretion 
of bile cholesterol, phospholipids and 
bile salts seems to be more or less inter-
dependent. Thus, studies have shown 
that the rates of biliary cholesterol and 
phospholipid excretion depend on the 
concentration of bile salts in the 
enterohepatic circulation.^ ^-^" It is there-
fore apparent that the ratio of micellar 
components could remain constant in 
spite of a drop in biliary bile salt con-
centrations. Such interdependence, of 
course, does not preclude the possibil-
ity of changes in the composition of the 
biliary bile salt pool which could affect 
cholesterol solubility. In view of the 
uncertainty regarding these interrela-
tionships, it was of interest to deter-
mine the effects of a hydrophilic 
mucoid and an anion exchange resin on 
the composition of bile lipids. 
In the following study, we deter-
mined what changes, if any, administra-
tion of the anion exchange resin, 
cholestyramine, or the hydrophilic 
mucoid, psyllium hydrocolloid, induced 
in the ratio of cholesterol: 
phospholipids: bile salts and in the bile 
salt composition of human hepatic bile. 
Protocol 
The subjects of this experiment were 
six post-cholecystectomy patients with 
normal liver function. Short-arm, T-tube 
catheters were placed in the common 
bile duct, and were clamped continu-
ously except during bile collections, 
which were begun at least three days 
prior to the start of the experimental 
control period. 
When the patients were in a convales-
cent phase, they were placed on a 
standard 1500 calorie diet containing 77 
gm protein, 138 gm carbohydrate and 70 
gm fat. Starting with the second day on 
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Table 
EFFECT OF PSYLLIUM HYDROCOLLOID ON HEPATIC BILE LIPID COMPOSITION 
(All values in mmoles/liter bile) 
Patient 
Days on 
Control or 
treatment* 
Choles-
terol 
Total 
Phospho- Cholic 
lipids acid 
BILE ACIDSt 
Chenode- Deoxy-
oxychollc cholic 
Total 
B.A. 
RATIO 
Cholesterol: 
Phospholipid: 
Total Bile Acid 
1. (f)t 
Control 6 2.65 6.18 10.88 7.70 1.54 20.1 1 : 2.35 : 7.60 
± 0.77 ± 1.96 ± 2.27 ± 2.14 ± 1.99 ± 3.8 ± 0.31 ± 2.60 
Treated 6 4.81 7.41 9.28 8.41 5.26 22.9 1 : 1.54 : 4.76 
± 0.96 ± 1.32 I 2.54 ± 2.49 ± 3.23 ±7.37 ± 0.44 ± 2.29 
2. (f) 
Control 3 2.60 3.70 15.1 19.6 5.81 40.5 1 : 1.42 : 15.6 
± 0.46 ± 0.88 ± 4.3 ± 4.6 ± 3.07 ± 6.4 ± 0.37 ± 2.2 
Treated 8 2.48 4.29 12.6 19,1 10 3 42.0 1 : 1.73 : 16.9 
3. (m) 
Control 
± 0.33 ± 0.50 ± 3.4 ± 2.6 ± 4.5 ± 5.7 ± 0.19 ± 2.4 
6 1.30 7.17 11.2 14.3 2.41 27.9 1 : 5.52 : 21.4 
± 0.35 ± 1.13 ± 2.80 ± 1.32 ± 0.16 ± 3.58 ± 0.80 ± 7.49 
Treated*' 29 1.35 7.89 11.0 14.4 10.9 36.4 1 : 5.85 : 27.0 
± 0.49 ± 1.57 ± 2.41 ± 3.40 ± 5.19 ± 7.46 ± 1.45 ± 7.08 
•Bile collected in A.M. and P.M. on second day and alternate days of control or treatment period. Therefore number of collec-
tions is equal to number of days in these periods. Values given are averages for the collected samples ± the Standard 
Deviation. Subjects received 3 gm psyllium hydrocolloid four times a day during treatment period. 
tPresent in bile as glycine and taurine conjugated bile salts. 
*Sex 
•"Bile collections made on the 2nd, 4th, 6th, 8th, 13th, 15th, 20th, 22nd, 27th, and 29th days. 
this diet, 10-20 ml bile collections were 
taken after breakfast and lunch every 
other day. Six to eight samples were 
collected from each patient during the 
control period. Following this period, 3 
gm of psyllium hydrocolloid''' was 
administered to three patients four 
times daily, before meals and at bed 
time. Four grams of cholestyramine* 
was given to the other three patients, 
three times daily. Bile collections were 
continued on alternate days during drug 
administration. An aliquot of bile was 
tCenerous gift of Fellows-Testagar Division 
of Fellows Medical Manufacturing Company. 
^Marketed by Merck Sharp & Dohme, Divi-
sion of Merck & Company Inc., under the 
trade name of Cuemid. 
taken from one collection on each 
patient and cultured for bacteria. 
Assay Methods 
Bile was assayed for bile salts, 
phospholipids, and cholesterol. Follow-
ing collection, duplicate samples of bile 
were dried by lyophilization, and the 
residues extracted with chloroform: 
methanol, 2:1 (v/v). Aliquots of these 
extracts, which contained the bile 
lipids, were used to determine total 
phospholipids^^ and conjugated bile 
salts. Second aliquots were used for 
determination of cholesterol and the 
free bile acids, which resulted from 
hydrolysis of conjugated bile salts. For 
these assays, the aliquots were 
evaporated to dryness, and then heated 
with 7 N sodium hydroxide at 15 lbs pres-
sure (autoclave) to hydrolyze bile acid 
conjugates and cholesterol esters. The 
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Table II 
EFFECT OF CHOLESTYRAMINE ON HEPATIC BILE LIPID COMPOSITION 
(All values in mmoles/liter bile) 
Patient 
Days on 
Control or Choles -
Treatment^ terol 
Total 
Phospho- Cholic 
lipids acid 
BiLE ACiDSt 
Chenode- Deoxy-
oxycholic cholic 
Total 
B.A. 
RATIO 
Choiesteroi: 
Phospholipid: 
Total Bile Acid 
4. (f)* 
Control 6 3.62 6.90 35.2 22.6 0.0 58.0 1 ; 1.91 : 16.02 
± 0.48 ± 1.17 ± 7.18 ± 4.98 ± 8,22 ± 0.34 ± 3.16 
Treated^^ 9 4.24 6.81 35.7 10.3 0.0 45.9 1 1.61 : 10.82 
± 0.83 ± 1.55 ± 5.64 ± 3.75 ± 7.90 ± 0.41 ± 4.12 
5. (f) 
Control 6 3.79 6.37 25.7 16.1 S3 47.1 1 1.68 : 12.32 
+ 0.55 ± 1.66 ± 7.69 ± 5.18 ± 4.42 ± 14.3 ± 0.26 ± 5.35 
Treated 8 3.44 5.97 29.4 7.25 0,0 36.7 1 1.74 : 10.67 
± 0.49 ± 1.31 ± 5.41 ± 1.77 ± 6.82 ± 0.27 ± 3.84 
6. (f) 
Control 6 2.17 0-90 6.98 3.20 11.9 1 0.39 : 5.16 
± 0.24 ± 0.26 ± 1.16 ± 1.17 ± 1.17 ± 3.05 ± 0.09 ± 0.71 
Treated 12 1.89 0.35 7.16 1.45 0 0 8.90 1 0.18 : 4.97 
± 0.56 ± 0.19 ± 1.18 ± 0.58 ± 2.31 ± 0.07 ± 1.09 
•Bile collected in A.M. and P.M. on second day and alternate days of control or treatment period. Therefore number of collec-
tions is equal to number of days in these periods. Values given are averages for the collected samples ± the Standard 
Deviation. Subjects received 4 gm cholestyramine three times daily during treatment period. 
tPresent in bile as glycine and taurine conjugated bile salts. 
•Sex 
••Bile collections made on the 2nd, 4th, 6th, 8th, and 9th days. 
alkaline hydrolysates were extracted 
with petroleum ether to recover the 
non-saponifiable material which con-
tains cholesterol. Cholesterol was deter-
mined according to Sperry and Webb. '^' 
The alkaline residues were acidified, 
and extracted with petroleum ether to 
remove fatty acids. The acidic residues 
were exhaustively extracted with ethyl 
ether to recover the "acidic fraction" 
containing free bile acids. 
Free and conjugated bile acids were 
separated and determined as follows: 
Thin-layer chromatographic plates were 
prepared by coating 20 by 20 cm glass 
plates with uniform 200 p. layers of Silica 
Gel C. After air drying, the plates were 
activated for two hours at 100" C. 
Aliquots of extracts containing either 
free or conjugated bile acids, together 
with appropriate standard solutions, 
were spotted on the activated plates. 
Plates spotted with conjugated bile 
acids were developed with toluene:gla-
cial acetic acid:water (7.5:12.5:1.0, 
v/v). To determine cholic acid, plates 
spotted with free bile acids were 
developed with ethyl acetate:glacial 
acetic acid (96:4, v/v). Other plates 
spotted with free bile acids were 
developed with ethyl acetate: 2,2,4-
trimethylpentane:glacial acetic acid 
(10:10:2, v/v) to assay chenodeoxycholic 
and/or deoxycholic acid. Following 
development, the plates were air dried 
and then sprayed to saturation with 
ethanolic phosphomolybdic acid (20%, 
wt/v). The sprayed plates were heated 
for 15 minutes at 100" C to effect color 
development. The concentrations of 
bile acids on the plates were then deter-
mined by scanning densitometry. '^'^ ^ 
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TABLE III 
EFFECT OF CHOLESTYRAMINE ON THE CONCENTRATION 
OF THE CONJUGATED BILE SALTS OF HEPATIC BILE 
(All values In mmoles/liter bile) 
BILE SALTS 
Patient 
Days on 
Control or 
Treat mont^ 
Giyco-
cholate 
Tauro-
cholate 
Glycocheno-
deoxycholate 
+ Glycodeoxy-
choiate 
Taurocheno-
deoxychoiate 
+ Taurodeoxy-
cholate 
Total 
Bile Salt 
Conjugates 
6. 
Control 6 3.18 
± 0.84 
2.25 
± 1.14 
3.79 
± 0.78 
1.36 
± 0.50 
10.58 
Treated 12 4.35 
± 0.85 
0.82 
± 0.35 
3.04 
± 0.84 
0.28 
± 0.37 
8.49 
•Bile collected in A.M. and P.M. on second day and alternate days of control or treatment period. Therefore number of collec-
tions is equal to number of days in these periods. Values given are averages for the collected samples ± the Standard 
Deviation. Subjects received 4 gm cholestyramine three times daily during treatment period. 
Results 
Tables I and II show concentrations of 
total cholesterol, total phospholipids, 
and the various bile salts, as well as the 
ratios of these lipids, in hepatic bile 
from six patients. The control data 
demonstrate that the composition of 
hepatic bile varied from patient to 
patient. However, for each individual 
patient's collections the variations in the 
lipid concentrations were relatively 
small, as shown by the standard devia-
tions. 
Data pertaining to the effects of psyl-
lium hydrocolloid on the hepatic bile 
lipids of three human subjects are 
shown in Table I. In Patient No. 1, there 
was a significant increase (P <.01) in the 
bile cholesterol concentration. This was 
reflected by a change in the ratio of the 
bile lipids. Since, however, there was 
no increase in bile cholesterol concen-
trations in Patients 2 and 3, it may be that 
the change in Patient 1 was unrelated to 
psyllium hydrocolloid treatment. 
No significant changes in total 
phospholipid, cholate or chenodeoxy-
cholate concentrations were observed 
in the bile of any of the patients. In each 
case, however, the deoxycholate con-
centration increased significantly (P < 
.01). Since the per cent change was 
minor in the hepatic bile of Patients 1 
and 2, this increase had only a small 
effect on the bile lipid ratio and the 
total bile acid concentration. However, 
in Patient 3, the percentage increase 
was larger and resulted in a significant 
(P < .01) change in the ratio of the bile 
lipids and a decided increase in the total 
bile salt concentration. Since Patient 3 
was treated with psyllium hydrocolloid 
for a much longer period than Patients 
1 an 2 and the deoxycholate concen-
tration increased with treatment time in 
all three patients, long-term mucoid 
treatment could consistently result in an 
increased total biliary bile salt concen-
tration and a changed bile salt com-
position. This possibility must be ver-
ified by further long-term experiments. 
Table II shows the effects of choles-
tyramine on the bile lipid concentra-
tions in three patients. There were no 
changes in the concentrations of bile 
cholesterol or cholate in any of the 
subjects treated with cholestyramine. 
There was a small but significant (P < 
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.01) decrease in the bile phospholipid in 
Patient 6; and deoxycholate was 
eliminated from the biliary bile salt 
pool in Patients 5 and 6. Cholestyramine 
treatment resulted in a decided 
decrease (P < .001) in the concentration 
of bile chenodeoxycholate in all three 
patients. As a result of the changes in 
bile salt composition, there was a tend-
ency for the total bile salt concentra-
tion to decrease. Since deviations from 
patient to patient were rather large, it is 
difficult to assess the significance of this 
decrease. Nevertheless the trend is 
there, and confirms a similar trend 
found by other investigators.^ '''^ " 
Table III presents data on the effects 
of cholestyramine on conjugated bile 
salt concentrations in hepatic bile of 
Patient 6. The data show that the resin 
increased the concentration of 
glycocholate, and decidedly decreased 
the concentrations of taurocholate, 
and taurochenodeoxycholate plus 
taurodeoxycholate. While one might 
have expected a compensating increase 
in the glycochenodeoxycholate plus 
glycodeoxycholate concentration, it 
must be remembered that choles-
tyramine treatment eliminated deoxy-
cholate from the hepatic bile spectrum 
(Table II) of this patient. 
Discussion 
The increased concentration of deoxy-
cholate in the hepatic bile of patients 
treated with psyllium hydrocolloid is of 
interest because it results in increases in 
the size of the total biliary bile salt pool 
and the ratio of total bile salts to choles-
terol in hepatic bile. Increases such as 
these have been shown to enhance 
biliary micelle stability,*"" and to pre-
vent gallstone formation and promote 
gallstone dissolution in experimental 
animals .Whi le this suggests that the 
increased deoxycholate concentration 
effected by psyllium hydrocolloid might 
result in less lithogenic bile, the rela-
tionship of bile micelle stability to deoxy-
cholate (a dihydroxy bile salt) concen-
tration has not been defined. It has, in 
fact, been theorized that micelles made 
up of cholestrol, lecithin and dihy-
droxy bile salts may be less stable than 
those made up with trihydroxy bile salts. 
"'^* This theory is based on the con-
cept that micelles containing the dihy-
droxy salts are larger and have less sur-
face charge than those containing 
trihydroxy bile salts. On the other hand, 
increases in biliary chenodeoxycholate 
(also a dihydroxy bile salt) concentra-
tion have been shown to actually effect 
the dissolution of gallstones."'^ '* 
The increased concentration of deoxy-
cholate in the bile of psyllium 
hydrocolloid-treated subjects is difficult 
to explain. Deoxycholate is a secondary 
bile salt produced in the distal ileum 
and the large intestine by the bacterial 
7Q:-dehydroxylation of cholate. It 
appears in bile following intestinal 
absorption, portal blood transport, and 
hepatic clearance and secretion. The 
fact that psyllium hydrocolloid increases 
the concentration of this anion in bile 
appears to argue against a bile acid-
sequestering role for this drug, since 
one would expect a sequestrant to 
lower the deoxycholate concentration 
by interrupting absorption of this intes-
tinally synthesized bile acid. Neverthe-
less it has been shown that the mucoid 
does increase bile acid excretion in 
man' and decreases the half-life of 
cholate in the bile acid pool of rats.^  It 
would therefore seem that either psyl-
lium hydrocolloid is an ineffective bind-
ing agent for deoxycholate or that there 
is an increase in deoxycholate produc-
tion which exceeds the ability of the 
mucoid to remove it. Increased produc-
tion of deoxycholate could result from 
a change in the bacterial population of 
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the distal ileum and large intestine. 
However, no studies have been made of 
the effects of psyllium hydrocolloid on 
intestinal bacteria. 
While the data pertaining to the 
effects of cholestyramine on hepatic 
bile lipid concentrations were obtained 
on only three subjects treated for rela-
tively short periods, the changes 
reported above have been observed by 
a number of investigators, 15.20,23,27-29 
and merit a rather detailed discussion. 
Cholestyramine administration results 
in a large increase in the trihydroxy to 
dihydroxy bile salt ratio and a marked 
increase in the ratio of glycine to 
taurine conjugates in bile. The increase 
in the former ratio is due to decreases 
in the concentrations of chenodeoxy-
cholate and deoxycholate anions. 
The decrease in chenodeoxycholate 
could be effected by at least two differ-
ent mechanisms. First, because dihyd-
roxy bile salt anions have a higher affin-
ity for cholestyramine than trihydroxy 
bile salt anions, "^-^ ^ one would expect 
cholestyramine to remove chenodeoxy-
cholate ions from the bile salt pool 
more rapidly than cholate ions. Since in 
human subjects treated with choles-
tyramine the synthesis of bile acids from 
cholesterol is rate-limiting, one would 
then expect an increase in the ratio of 
trihydroxy to dihydroxy bile salts in bile. 
A second possibility is that choles-
tyramine may effect a change in the rate 
of bile acid synthesis at the enzyme 
level. Such a change could result in an 
increase in cholic acid synthesis at the 
expense of chenodeoxycholic acid 
synthesis.While this is an attractive 
hypothesis, no change in the activity of 
the 12a-hydroxylase of cholest-
4-en-7a-o1-3-one is seen in choles-
tryamin-treated rats.^ ^ 
The decrease in deoxycholic acid con-
centration is more easily explained. As 
mentioned above, deoxycholate is a 
secondary bile salt produced by 
7a-dehydroxylation of cholate anions by 
the intestinal flora. One would expect 
the concentration of this bile salt to 
drop precipitously in cholestyramine-
treated subjects, since absorption of the 
intestinally synthesized bile salt would 
be retarded by resin. This effect of 
cholestyramine contrasts with the 
increased concentration of deoxycholic 
acid which appears during psyllium hy-
drocolloid treatment. 
The increase in the glycine to taurine 
conjugate ratio probably stems from 
exhaustion of the limited hepatic 
taurine supply and the fact that 
cholestyramine preferentially seques-
ters taurine conjugates.The increased 
rate of hepatic bile acid synthesis 
effected by cholestyramine increases 
the need for the limited supply of 
taurine available for bile acid con-
jugation, and conjugation shifts to the 
more readily available glycine. 
Although cholestyramine effects 
significant changes in the di- to tri-
hydroxy bile salt and glycine to taurine 
conjugate ratios in bile, its effect on the 
ratio of cholesterol/phospholipids/bile 
salts, which is an important factor deter-
mining bile micelle stability, is uncer-
tain. Our results, together with those of 
some others, suggest a decrease in 
bile acid concentrations; however, 
other investigators find no change. 
When the data obtained in one 
experiment" was plotted, using the 
triangular coordinate system of Small, 
Bourges and Dervichian,' there was no 
indication that cholestyramine treat-
ment led to the formation of unstable 
biliary micelles. However, caution must 
be used in interpreting these results 
since the use of phase relationships in 
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a solut ion as complex as bile is not infal-
l i b l e and takes no accoun t o f t h e 
changes in bile acid anion composi t ion 
that result f rom cholestyramine treat-
ment. 
The shift toward tr ihydroxy bile salts 
w o u l d appear to result in more stable 
m i c e l l e s . " ' " H o w e v e r , s tud ies have 
shown that bile rich in chenodeoxy-
cholate effects dissolut ion of gall-
s tones .^^ ' " The shi f t in the g lyc ine to 
taurine conjugate ratio wou ld appear to 
result in more stable bile micelles, since 
glycine conjugates appear to be more 
e f f i c ien t cho les tero l so lub i l izers than 
taurine conjugates.2° 
From the f o rego ing d iscuss ion , it is 
obvious that no def ini te conclusions as 
t o the e f fec ts o f c h o l e s t y r a m i n e on 
b i l i a ry c h o l e s t e r o l s o l u b i l i t y can be 
made at th is t i m e . Since th is resin is 
used in the l o n g - t e r m t r e a t m e n t of 
hype rcho les te ro lem ia , it is obv ious ly 
important to devise experiments which 
wi l l def ine more precisely the complex 
in ter re la t ionsh ips invo lved in mice l le 
s tab i l i ty , and to de te rm ine the actual 
effects of anion exchange polymers on 
their stability. 
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